Notify me when GLENVIEW CAPITAL MANAGEMENT, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 53 | $4,114,788,655 | +$874,085,748 | -$503,282,574 | +$370,803,174 | CVS, THC, GPN, TEVA, GTM | 13F-HR | 14 Nov 2025, 16:16 |
| Q2 2025 | 42 | $3,523,902,220 | +$464,388,503 | -$1,168,609,644 | -$704,221,141 | CVS, THC, GPN, TEVA, GTM | 13F-HR | 14 Aug 2025, 16:40 |
| Q1 2025 | 44 | $4,049,434,837 | +$636,521,959 | -$548,894,931 | +$87,627,028 | CVS, THC, GPN, TEVA, ALIT | 13F-HR | 15 May 2025, 16:11 |
| Q4 2024 | 36 | $3,955,088,048 | +$586,086,145 | -$979,978,177 | -$393,892,032 | CVS, GPN, THC, ALIT, TEVA | 13F-HR | 14 Feb 2025, 16:22 |
| Q3 2024 | 43 | $4,737,542,715 | +$769,761,034 | -$1,193,653,565 | -$423,892,531 | CVS, THC, GPN, CI, CTVA | 13F-HR | 14 Nov 2024, 16:17 |
| Q2 2024 | 46 | $4,720,313,868 | +$916,142,909 | -$1,147,566,993 | -$231,424,084 | THC, CVS, CI, GPN, CTVA | 13F-HR | 14 Aug 2024, 16:09 |
| Q1 2024 | 43 | $5,130,931,148 | +$998,402,400 | -$785,726,776 | +$212,675,624 | THC, CI, CTVA, UHS, GPN | 13F-HR | 15 May 2024, 16:23 |
| Q4 2023 | 41 | $4,291,409,278 | +$804,655,020 | -$699,228,643 | +$105,426,377 | CI, THC, DXC, UHS, GPN | 13F-HR | 14 Feb 2024, 16:26 |
| Q3 2023 | 47 | $3,675,781,949 | +$779,391,564 | -$495,813,208 | +$283,578,356 | THC, CI, UHS, GPN, DXC | 13F-HR | 14 Nov 2023, 16:30 |
| Q2 2023 | 46 | $3,722,860,559 | +$342,709,356 | -$1,135,339,810 | -$792,630,454 | CI, THC, DXC, UHS, GPN | 13F-HR | 14 Aug 2023, 16:13 |
| Q1 2023 | 53 | $4,066,660,131 | +$549,145,117 | -$773,252,893 | -$224,107,776 | CI, THC, FI, GPN, DXC | 13F-HR | 15 May 2023, 16:18 |
| Q4 2022 | 51 | $4,172,324,241 | +$636,565,008 | -$752,268,112 | -$115,703,104 | CI, THC, DXC, FI, MCK | 13F-HR | 14 Feb 2023, 16:21 |
| Q3 2022 | 53 | $3,944,130,000 | +$667,466,077 | -$556,037,460 | +$111,428,617 | CI, THC, FI, DXC, GPN | 13F-HR | 14 Nov 2022, 16:12 |
| Q2 2022 | 53 | $3,933,395,000 | +$648,752,511 | -$806,442,068 | -$157,689,557 | CI, THC, GPN, DXC, MCK | 13F-HR | 11 Aug 2022, 16:15 |
| Q1 2022 | 58 | $4,904,279,000 | +$1,075,489,180 | -$847,972,269 | +$227,516,911 | THC, CI, GPN, MCK, DXC | 13F-HR | 16 May 2022, 16:43 |
| Q4 2021 | 54 | $4,607,253,000 | +$379,454,862 | -$1,603,055,913 | -$1,223,601,051 | THC, MCK, BHC, GPN, CI | 13F-HR | 14 Feb 2022, 17:05 |
| Q3 2021 | 2 | $55,140,000 | $0 | $0 | $0 | QSI, EVLV | New Holdings | 18 Feb 2022, 17:16 |
| Q3 2021 | 60 | $5,482,206,000 | +$738,103,463 | -$1,002,364,051 | -$264,260,588 | THC, BHC, MCK, CI, COR | 13F-HR | 15 Nov 2021, 16:38 |
| Q2 2021 | 65 | $6,036,560,000 | +$1,234,429,765 | -$1,452,477,616 | -$218,047,851 | THC, BHC, CI, MCK, DXC | Restatement | 18 Feb 2022, 17:16 |
| Q1 2021 | 63 | $5,902,367,000 | +$1,794,510,005 | -$1,023,848,936 | +$770,661,069 | THC, BHC, CI, MCK, DXC | 13F-HR | 17 May 2021, 16:06 |
| Q4 2020 | 54 | $4,284,829,000 | +$638,331,691 | -$497,788,248 | +$140,543,443 | THC, BHC, TAK, DXC, CI | 13F-HR | 16 Feb 2021, 16:16 |
| Q3 2020 | 45 | $3,185,857,000 | +$121,830,923 | -$858,166,410 | -$736,335,487 | THC, TAK, BHC, CI, HCA | 13F-HR | 16 Nov 2020, 16:09 |
| Q2 2020 | 43 | $3,615,851,000 | +$508,217,874 | -$1,372,881,161 | -$864,663,287 | THC, TAK, BHC, CI, HCA | 13F-HR | 14 Aug 2020, 16:06 |
| Q1 2020 | 44 | $3,678,491,000 | +$238,635,009 | -$4,797,382,285 | -$4,558,747,276 | TAK, THC, CI, BHC, HCA | 13F-HR | 15 May 2020, 16:07 |
| Q4 2019 | 50 | $11,424,422,000 | +$2,011,097,217 | -$1,901,622,218 | +$109,474,999 | HCA, CI, THC, PARA, TAK | 13F-HR | 14 Feb 2020, 16:18 |
| Q3 2019 | 49 | $9,505,554,000 | +$1,045,653,683 | -$2,036,345,966 | -$990,692,283 | CI, HCA, MCK, IQV, TAK | 13F-HR | 14 Nov 2019, 16:07 |
| Q2 2019 | 46 | $11,034,823,000 | +$1,083,756,321 | -$1,187,830,848 | -$104,074,527 | CI, HCA, IQV, FMC, MCK | 13F-HR | 14 Aug 2019, 16:07 |
| Q1 2019 | 45 | $11,206,048,000 | +$2,925,545,010 | -$3,346,693,310 | -$421,148,300 | DXC, FMC, CI, MCK, IQV | 13F-HR | 15 May 2019, 16:06 |
| Q4 2018 | 48 | $10,262,409,000 | +$1,816,381,560 | -$4,736,851,537 | -$2,920,469,977 | SHPG, FMC, IQV, HCA, CVS | 13F-HR | 14 Feb 2019, 16:12 |
| Q3 2018 | 57 | $15,692,407,000 | +$1,934,442,758 | -$2,138,199,690 | -$203,756,932 | ESRX, FMC, AET, IQV, MCK | 13F-HR | 14 Nov 2018, 16:09 |
| Q2 2018 | 50 | $14,659,371,000 | +$935,839,308 | -$3,825,708,635 | -$2,889,869,327 | SHPG, DWDP, FMC, MCK, THC | 13F-HR | 14 Aug 2018, 16:08 |
| Q1 2018 | 53 | $17,075,649,000 | +$1,969,452,242 | -$2,649,477,294 | -$680,025,052 | HCA, SHPG, DWDP, FMC, IQV | 13F-HR | 15 May 2018, 16:07 |
| Q4 2017 | 58 | $18,498,474,000 | +$4,496,383,338 | -$4,064,967,404 | +$431,415,934 | HCA, DWDP, FMC, SHPG, IQV | 13F-HR | 14 Feb 2018, 16:26 |
| Q3 2017 | 56 | $17,234,823,000 | +$3,497,535,068 | -$2,270,007,568 | +$1,227,527,500 | HCA, DWDP, FMC, SHPG, Q | 13F-HR | 14 Nov 2017, 16:18 |
| Q2 2017 | 52 | $15,412,521,000 | +$2,671,572,937 | -$3,049,581,376 | -$378,008,439 | HCA, FMC, DOW, Q, ELV | 13F-HR | 14 Aug 2017, 16:26 |
| Q1 2017 | 51 | $15,050,533,000 | +$1,360,385,735 | -$2,548,117,166 | -$1,187,731,431 | HCA, HUM, ELV, DOW, FMC | 13F-HR | 15 May 2017, 16:23 |
| Q4 2016 | 48 | $14,772,850,000 | +$2,783,388,113 | -$2,334,090,229 | +$449,297,884 | HCA, HUM, ELV, CI, AET | 13F-HR | 14 Feb 2017, 16:25 |
| Q3 2016 | 50 | $13,981,715,000 | +$2,135,527,791 | -$2,743,459,367 | -$607,931,576 | HUM, HCA, CI, CBS, ELV | 13F-HR | 14 Nov 2016, 16:20 |
| Q2 2016 | 47 | $14,144,349,000 | +$1,701,555,865 | -$1,554,774,921 | +$146,780,944 | HUM, HCA, MON, CI, ABBV | 13F-HR | 15 Aug 2016, 16:10 |
| Q1 2016 | 45 | $13,679,334,000 | +$478,365,702 | -$4,239,225,109 | -$3,760,859,407 | HUM, HCA, MON, CI, ABBV | 13F-HR | 16 May 2016, 16:11 |
| Q4 2015 | 55 | $17,759,998,000 | +$2,840,622,895 | -$5,439,362,349 | -$2,598,739,454 | HUM, MON, CI, HCA, TMO | 13F-HR | 16 Feb 2016, 16:52 |
| Q3 2015 | 78 | $20,151,961,000 | +$2,253,554,459 | -$3,664,874,623 | -$1,411,320,164 | HUM, MON, TMO, ABBV, FLEX | 13F-HR | 16 Nov 2015, 16:11 |
| Q2 2015 | 81 | $25,250,153,000 | +$6,558,906,894 | -$3,562,638,182 | +$2,996,268,712 | HUM, TMO, ABBV, MON, THC | 13F-HR | 14 Aug 2015, 16:11 |
| Q1 2015 | 80 | $21,898,981,000 | +$4,197,744,052 | -$2,908,630,255 | +$1,289,113,797 | MON, FLEX, TMO, HUM, ELV | 13F-HR | 15 May 2015, 16:18 |
| Q4 2014 | 74 | $19,978,752,000 | +$3,144,271,163 | -$3,313,242,112 | -$168,970,949 | TMO, MON, FLEX, THC, CYH | 13F-HR | 17 Feb 2015, 16:13 |
| Q3 2014 | 74 | $19,126,619,000 | +$4,141,447,882 | -$2,421,755,990 | +$1,719,691,892 | TMO, MON, THC, FLEX, HCA | 13F-HR | 14 Nov 2014, 16:09 |
| Q2 2014 | 68 | $17,182,048,000 | +$3,760,946,101 | -$2,506,319,245 | +$1,254,626,856 | TMO, MON, FLEX, HCA, THC | 13F-HR | 14 Aug 2014, 16:14 |
| Q1 2014 | 65 | $15,140,336,000 | +$4,180,207,189 | -$2,546,776,575 | +$1,633,430,614 | TMO, MON, HCA, CCI, THC | 13F-HR | 15 May 2014, 16:10 |
| Q4 2013 | 60 | $13,157,705,000 | $0 | $0 | $0 | TMO, HCA, THC, MON, CCI | 13F-HR | 14 Feb 2014, 16:20 |